Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes
在有心血管风险的2型糖尿病患者中,基于肠促胰素的药物:比较GLP-1受体激动剂和DPP-4抑制剂对心血管和胰腺结局的影响
期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-017-0512-z
Zhang, Zeqing; Chen, Xi; Lu, Puhan; Zhang, Jianhua; Xu, Yongping; He, Wentao; Li, Mengni; Zhang, Shujun; Jia, Jing; Shao, Shiying; Xie, Junhui; Yang, Yan; Yu, Xuefeng